You are here

  • Home
  • Archive
  • Volume 65, Issue 7
  • Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register

Article info

Article menu
Download PDFPDF
Extended reports
Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register

Authors

Other Contributors 
  • , 2Members of BSRBR Control Centre Consortium (see the appendix)
  1. Correspondence to:
    Professor A Silman
    ARC Unit, University of Manchester, Manchester, UK; a.silman{at}manchester.ac.uk
View Full Text

Citation

Hyrich K, Symmons D, Watson K on behalf of the British Society for Rheumatology Biologics Register, et al
Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register
Annals of the Rheumatic Diseases 2006;65:895-898.

Publication history

  • Accepted November 4, 2005
  • First published December 8, 2005.
Online issue publication 
January 09, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Copyright 2006 by Annals of the Rheumatic Diseases